Probably worth asking, however it's also worth noting that if he...

Probably worth asking, however it's also worth noting that if he were to say anything other than management remains confident then the company would almost certainly be in breach of Listing Rule 3.1. My rationale for this is as follows:
At present ongoing funding is existential for the company. Given this, any change in the advice provided in the quarterly concerning funding would have to have been disclosed to the market else the company would be in breach of Listing Rule 3.1, and would potentially be facilitating a false market in the company's shares. As it stands the company is possibly in breach of this rule at present or skirting on the edge of a breach, given no information about funding has been forthcoming since the quarterly was released and even then, the info was very similar to that provided at the AGM (differences as described in @MoneyBags1348 earlier post). That amounts to approx 5 months without clarity. One would reasonably expect that details of one or more of the funding options should have been disclosed to the market by now.
Inchoate does not mean indefinite and confidentiality is not an allowable reason for non-disclosure.